| 國立成功大學 |
2023 |
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
|
Cheng, S.-H.;Lien, C.E.;Hsieh, S.-M.;Cheng, Cheng C.-Y.;Liu, W.-D.;Lo, C.-L.;Ko, W.-C.;Chen, Y.-H.;Huang, C.-T.;Chang, H.-T.;Hwang, S.-J.;Wang, N.-C.;Liu, M.-C.;Lee, Y.-L.;Tai, I.-C.;Estrada, J.A.G.;Lin, T.-Y.;Lee, W.-S. |
| 國立成功大學 |
2023 |
Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study
|
Tsai, C.-Y.;Chen, G.-J.;Tsai, C.-S.;Liou, B.-H.;Yang, C.-J.;Tsai, H.-C.;Lin, C.-Y.;Huang, S.-H.;Lin, K.-Y.;Wang, N.-C.;Chen, T.-C.;Lee, C.-H.;Hung, C.-C. |
| 國立成功大學 |
2023 |
An Efficient Lane Following Navigation Strategy With Fusion Attention for Autonomous Drones in Urban Areas
|
Lee, C.-Y.;Khanum, A.;Wang, N.-C.;Karuparthi, B.S.K.;Yang, C.-S. |
| 臺大學術典藏 |
2022-09-15T05:42:28Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun H.-Y.; Cheng C.-Y.; Lin C.-Y.; Yang C.-J.; Lee N.-Y.; Liou B.-H.; Tang H.-J.; Liu Y.-M.; Lee C.-Y.; Chen T.-C.; Huang Y.-C.; Lee Y.-T.; Tsai M.-J.; Lu P.-L.; Tsai H.-C.; Wang N.-C.; Hung T.-C.; Cheng S.-H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-05-13T08:05:20Z |
Antibiotic usage in community-acquired infections in hospitals in Taiwan
|
Ho M.; Chang F.-Y.; Yin H.-C.; Ben R.-J.; Chang L.-Y.; Chen P.-Y.; Cheng S.-H.; Chen S.-T.; Huang F.-L.; Lin H.-C.; Lu D.C.T.; Wang N.-C.; JANN-TAY WANG |
| 國立成功大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, H.-Y.;Cheng, Cheng C.-Y.;Lin, C.-Y.;Yang, C.-J.;Lee, N.-Y.;Liou, B.-H.;Tang, H.-J.;Liu, Y.-M.;Lee, C.-Y.;Chen, T.-C.;Huang, Y.-C.;Lee, Y.-T.;Tsai, M.-J.;Lu, P.-L.;Tsai, H.-C.;Wang, N.-C.;Hung, T.-C.;Cheng, S.-H.;Hung, C.-C. |
| 國立成功大學 |
2022 |
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up
|
Lin, K.-Y.;Yang, C.-J.;Sun, H.-Y.;Lee, Y.-T.;Liou, B.-H.;Hii, I.-M.;Chen, T.-C.;Huang, S.-H.;Lee, C.-Y.;Tsai, C.-S.;Lin, C.-Y.;Liu, C.-E.;Chang, H.-Y.;Cheng, Cheng C.-Y.;Lu, P.-L.;Hung, C.-C.;Huang, Y.-S.;Liu, W.-D.;Chen, G.-J.;Liu, W.-C.;Su, Y.-C.;Wu, P.-Y.;Chen, L.-Y.;Zhang, J.-Y.;Tsai, M.-S.;Lin, C.-C.;Lee, Y.-L.;Chen, Y.-H.;Huang, Y.-C.;Ko, W.-C.;Cheng, S.-H.;Chang, S.-Y.;Wang, N.-C.;Lin, T.-Y.;Lee, Y.-C.;Lin, S.-P.;Hsieh, C.-Y.;Wang, H.-W.;Ho, M.-W.;Hung, T.-C.;Tsai, H.-C.;Lin, H.-H.;Lee, C.-H.;Group, Taiwan HIV Study |
| 臺大學術典藏 |
2021-12-01T02:30:34Z |
Correlates of antibiotic use in Taiwan hospitals
|
McDonald L.C.; Yu H.T.; Yin H.C.; Hsiung C.A.; CHIEN-CHING HUNG; Ho M.; Gung C.; Gung S.-T.; Hsu M.-C.; Ben R.-J.; Lu D.C.T.; Lin H.-C.; Cheng S.-H.; Chen Y.-H.; Chen P.-Y.; Huang F.-L.; Chang F.-Y.; Wang N.-C.; Antibiotic Use Working Group |
| 臺大學術典藏 |
2021-12-01T02:29:13Z |
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
|
Cahn P.; Madero J.S.; Arribas J.R.; Antinori A.; Ortiz R.; Clarke A.E.; CHIEN-CHING HUNG; Rockstroh J.K.; Girard P.-M.; Sievers J.; Man C.; Currie A.; Underwood M.; Tenorio A.R.; Pappa K.; Wynne B.; Fettiplace A.; Gartland M.; Aboud M.; Smith K.; Cassetti L.; David D.; Figueras L.; Losso M.; Lopardo G.; Lupo S.; Porteiro N.; S?nchez M.; Bloch M.; Cooper D.; Finlayson R.; Kelleher A.; Koh K.; Lewis D.; McMahon J.; Moore R.; Roth N.; Shields M.; De Wit S.; Florence E.; Goffard J.-C.; Demeester R.; Lacor P.; Vandercam B.; Vandekerckhove L.; Angel J.; Baril J.-G.; Conway B.; De Pokomandy A.; Szabo J.; Walmsley S.; Bouchaud O.; Chidiac C.; Delobel P.; Goujard C.; Katlama C.; Molina J.-M.; Pialoux G.; Philibert P.; Bogner J.; Esser S.; Krznaric I.; Lehmann C.; Spinner C.; Stellbrink H.-J.; Stephan C.; Stoehr A.; Barchi E.; Caramello P.; Castelli F.; Cattelan A.M.; D'Arminio Monforte A.; Di Biagio A.; Di Perri G.; Gori A.; Maggiolo F.; Menzaghi B.; Migliorino G.; Mussini C.; Penco G.; Puoti M.; Rizzardini G.; Gulminetti R.; Lazzarin A.; Quirino T.; Sighinolfi L.; Viale P.; Amaya Tapia G.; Andrade Villanueva J.; Granados Reyes E.R.; Perez Rios A.; Santoscoy Gomez M.; Den Hollander J.; Rijnders B.; Hidalgo J.A.; Hercilla Vasquez L.; Illescas L.; Olczak A.; Mansinho K.; Correia Pacheco P.P.; Te?filo E.; Saraiva da Cunha J.; Sarmento e Castro R.; Serr?o R.; Arbune M.; Jianu C.; Oprea A.; Preotescu L.; Prisacariu L.-J.; Belonosova E.; Borodkina O.; Chernova O.; Gankina N.; Kizhlo S.; Kulagin V.; Kurina N.; Nagimova F.; Pokrovsky V.; Ryamova E.; Voronin E.; Yakovlev A.; Kaplan R.; Lee S.H.; Kim S.-W.; Kim S.-I.; Kim W.J.; Antela Lopez A.; Casado Osorio J.L.; Casta?o Carracedo M.A.; De Los Santos Gil I.; Estrada Perez V.; Falco Ferrer V.; Force L.; Galinda Puerto M.J.; Garcia Deltoro M.; Gatell J.M.; Goenaga Sanchez M.A.; Gonz?lez Cord?n A.; Knobel H.; Lopez Bernaldo de Quiros J.C.; Losa Garcia J.E.; Masia M.; Montero-Alsonso M.; Ocampo Hermida A.; Pasquau Lia?o J.; Portilla Sogorb J.; Pulido Ortega F.; Rivera Roman A.; Santos Fernandez J.R.; Torres Perea R.; Troya Garcia J.; Viciana Fernandez P.; Calmy A.; Hauser C.; Fehr J.; Cheng S.-H.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Tseng Y.-T.; Wang N.-C.; Wong W.-W.; Yang C.-J.; Arduino R.; Benson P.; Berhe M.; Bredeek F.; Brinson C.; Campbell T.; Crofoot G.; Cunningham D.; DeJesus E.; Dretler R.; Eron J.; Fife K.; Fichtenbaum C.; Flamm J.; Goldstein D.; Gupta S.; Hagins D.; Hoffman-Terry M.; Jayaweera D.; Kinder C.; Klein D.; McDonald C.; Mills A.; Nahass R.; Osiyemi O.; Overton E.; Parks D.; Prelutsky D.; Ramgopal M.; Schrader S.; Sha B.; Simon G.; Sims J.; Skiest D.; Slim J.; Tashima K.; Thedinger B.; Gazzard B.; Fox J.; Johnson M.; Kegg S.; Khoo S.; Mazhude C.; Orkin C.; Schembri G.; Ustianowski A.; GEMINI Study Team |
| 臺大學術典藏 |
2021-12-01T02:29:10Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; Lin K.-Y.; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; CHIEN-CHING HUNG; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-12-01T02:29:09Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; Lin K.-Y.; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; CHIEN-CHING HUNG; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:47Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:46Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:08Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:07Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:03Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:35Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
|
Li C.-W.; Yang C.-J.; Sun H.-Y.; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; YU-SHAN HUANG; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study
|
Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; YU-SHAN HUANG; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; Hung C.-C.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YU-SHAN HUANG; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-16T08:36:11Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-06-24T07:16:56Z |
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
|
Kao T.M.; Hsieh S.M.; Kung H.C.; Lee Y.C.; Huang K.C.; LI-MIN HUANG; Chang F.Y.; Wang N.C.; Liu Y.C.; Lee W.S.; Liu H.E.; Chen C.I.; Chen C.-H. |
| 臺大學術典藏 |
2021-06-24T07:16:55Z |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Kung H.-C.; Huang K.-C.; Kao T.-M.; Lee Y.-C.; Chang F.-Y.; Wang N.-C.; Liu Y.-C.; Lee W.-S.; Liu H.-J.; Chen C.-I.; Chen C.-H.; LI-MIN HUANG; Hsieh S.-M. |
| 臺大學術典藏 |
2021-05-06T01:52:01Z |
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
|
Wu U.-I.; Hsieh S.-M.; Lee W.-S.; Wang N.-C.; Kung H.-C.; Ou T.-Y.; Chen F.-L.; Lin T.-Y.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:25:13Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-04-20T03:46:09Z |
Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: A case-control study
|
Chan M.-C.;Chiu S.-K.;Hsueh P.-R.;Wang N.-C.;Wang C.-C.;Chi-Tai Fang; Chan M.-C.; Chiu S.-K.; Hsueh P.-R.; Wang N.-C.; Wang C.-C.; CHI-TAI FANG |
| 臺大學術典藏 |
2021-02-26T02:00:03Z |
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia
|
Lu C.-L.; Lin Y.-H.; Wong W.-W.; Lin H.-H.; Ho M.-W.; Wang N.-C.; Hsieh S.-M.; WANG-HUEI SHENG; Hung C.-C.; Chen M.-Y. |
| 臺大學術典藏 |
2021-01-14T03:09:06Z |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Kung H.-C.; KUO-CHIN HUANG; Kao T.-M.; Lee Y.-C.; Chang F.-Y.; Wang N.-C.; Liu Y.-C.; Lee W.-S.; Liu H.-J.; Chen C.-I.; Chen C.-H.; Huang L.-M.; Hsieh S.-M. |
| 臺大學術典藏 |
2021-01-14T03:09:06Z |
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
|
Kao T.M.; Hsieh S.M.; Kung H.C.; Lee Y.C.; KUO-CHIN HUANG; Huang L.M.; Chang F.Y.; Wang N.C.; Liu Y.C.; Lee W.S.; Liu H.E.; Chen C.I.; Chen C.-H. |
| 國立成功大學 |
2021 |
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
|
Hsieh, S.-M.;Liu, M.-C.;Chen, Y.-H.;Lee, W.-S.;Hwang, S.-J.;Cheng, S.-H.;Ko, W.-C.;Hwang, K.-P.;Wang, N.-C.;Lee, Y.-L.;Lin, Y.-L.;Shih, Shih S.-R.;Huang, C.-G.;Liao, C.-C.;Liang, J.-J.;Chang, Chang C.-S.;Chen, Chen C.;Lien, C.E.;Tai, I.-C.;Lin, T.-Y. |
| 國立成功大學 |
2021 |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin, J.-J.;Lin, K.-Y.;Tang, H.-J.;Lin, S.-P.;Lee, Y.-C.;Liu, C.-E.;Huang, Y.-S.;Wang, N.-C.;Li, C.-W.;Ko, W.-C.;Yang, H.-J.;Lee, Y.-T.;Hung, C.-C.;Group, Taiwan HIV Study |
| 國立成功大學 |
2021 |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou, B.-H.;Sun, H.-Y.;Yang, C.-J.;Syue, L.-S.;Lee, Y.-L.;Tang, H.-J.;Tsai, H.-C.;Lin, C.-Y.;Chen, T.-C.;Lee, C.-Y.;Huang, S.-H.;Liu, C.-W.;Lu, P.-L.;Lin, S.-P.;Wang, N.-C.;Cheng, A.;Ko, W.-C.;Cheng, S.-H.;Hung, C.-C.;Group, the Taiwan HIV Study |
| 國立成功大學 |
2021 |
Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
|
Huang, S.-H.;Lee, C.-Y.;Tsai, C.-S.;Tsai, M.-S.;Liu, C.-E.;Hsu, W.-T.;Chen, H.-A.;Liu, W.-D.;Yang, C.-J.;Sun, H.-Y.;Ko, W.-C.;Lu, P.-L.;Lee, Y.-T.;Hung, C.-C.;Sun, H.-Y.;Huang, Y.-S.;Chang, S.-Y.;Wu, P.-Y.;Chen, L.-Y.;Zhang, J.-Y.;Chang, H.-Y.;Liu, W.-C.;Su, Y.-C.;Hung, C.-C.;Wang, N.-C.;Lin, T.-Y.;Lin, K.-Y.;Yang, C.-J.;Chen, H.-A.;Tsai, M.-S.;Lee, Y.-C.;Cheng, Cheng C.-Y.;Cheng, S.-H.;Huang, Y.-C.;Huang, S.-H.;Lee, Y.-T.;Lin, J.-J.;Lin, S.-P.;Hsieh, C.-Y.;Wang, H.-W.;Ho, M.-W.;Liu, C.-E.;Lee, Y.-L.;Chen, G.-J.;Lin, C.-Y.;Hung, T.-C.;Tang, H.-J.;Ku, H.-C.;Li, C.-W.;Tsai, C.-S.;Lee, N.-Y.;Ko, W.-C.;Lu, P.-L.;Lee, C.-Y.;Chen, Y.-H.;Lee, C.-H.;Tsai, H.-C.;Che, T.-C.;Group, Taiwan HIV Study |
| 臺大學術典藏 |
2020-12-29T06:37:49Z |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Huang L.-M.; SZU-MIN HSIEH; Chen C.-H.; Chen C.-I.; Lee W.-S.; Liu H.-J.; Liu Y.-C.; Wang N.-C.; Chang F.-Y.; Lee Y.-C.; Kao T.-M.; Kung H.-C.; Huang K.-C. |
| 臺大學術典藏 |
2020-12-29T06:37:49Z |
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
|
Liu H.E.; Lee W.S.; Liu Y.C.; Wang N.C.; Chang F.Y.; Huang L.M.; Huang K.C.; Lee Y.C.; Kung H.C.; SZU-MIN HSIEH; Kao T.M.; Chen C.I.; Chen C.-H. |
| 臺大學術典藏 |
2020-12-29T06:37:48Z |
A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study
|
SZU-MIN HSIEH; Chang M.; Hsu Y.-S.; Liu M.-C.; Pai H.-C.; Chen T.-J.; Wang N.-C.; Lee W.-S.; Hsu W.-T.; Pan S.-C. |
| 臺大學術典藏 |
2020-12-29T06:37:36Z |
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia
|
Wong W.-W.; Lu C.-L.; Lin Y.-H.; Lu C.-L.;Lin Y.-H.;Wong W.-W.;Lin H.-H.;Ho M.-W.;Wang N.-C.;Szu-Min Hsieh;Sheng W.-H.;Hung C.-C.;Chen M.-Y.; Lin H.-H.; Ho M.-W.; Wang N.-C.; SZU-MIN HSIEH; Sheng W.-H.; Hung C.-C.; Chen M.-Y. |
| 臺大學術典藏 |
2020-12-29T05:33:48Z |
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
|
Li C.-W.;Yang C.-J.;Hsin-Yun Sun;Tsai M.-S.;Lin S.-P.;Lin T.-Y.;Cheng C.-Y.;Lee Y.-C.;Huang Y.-S.;Liu C.-E.;Lee Y.-T.;Tang H.-J.;Wang N.-C.;Cheng S.-H.;Ko W.-C.;Hung C.-C.; Hung C.-C.; Ko W.-C.; Cheng S.-H.; Tang H.-J.; Wang N.-C.; Lee Y.-T.; Li C.-W.; Yang C.-J.; HSIN-YUN SUN; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; Huang Y.-S.; Liu C.-E. |
| 臺大學術典藏 |
2020-12-29T03:09:28Z |
Antibiotic usage in community-acquired infections in hospitals in Taiwan
|
Chen S.-T.; Cheng S.-H.; Chen P.-Y.; Chang L.-Y.; Ben R.-J.; Yin H.-C.; Ho M.;Chang F.-Y.;Yin H.-C.;Ben R.-J.;Chang L.-Y.;Chen P.-Y.;Cheng S.-H.;Chen S.-T.;Huang F.-L.;Lin H.-C.;Lu D.C.T.;Wang N.-C.;Jann-Tay Wang; Ho M.; Chang F.-Y.; Huang F.-L.; Lin H.-C.; Lu D.C.T.; Wang N.-C.; JANN-TAY WANG |
| 臺大學術典藏 |
2020-12-24T08:57:01Z |
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
|
Ou T.-Y.; Kung H.-C.; Wang N.-C.; Lee W.-S.; Hsieh S.-M.; UN-IN WU; Un-In Wu;Hsieh S.-M.;Lee W.-S.;Wang N.-C.;Kung H.-C.;Ou T.-Y.;Chen F.-L.;Lin T.-Y.;Chen Y.-C.;Chang S.-C.; Chang S.-C.; Chen F.-L.; Lin T.-Y.; Chen Y.-C. |
| 臺大學術典藏 |
2020-12-18T08:37:39Z |
Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: A case-control study
|
Fang C.-T.; Wang C.-C.; Wang N.-C.; Chan M.-C.;Chiu S.-K.;Po-Ren Hsueh;Wang N.-C.;Wang C.-C.;Fang C.-T.; Chan M.-C.; Chiu S.-K.; PO-REN HSUEH |
